Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 98 citing Henry: Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic.... (0.08 sec) 

Clinical pharmacokinetics and pharmacodynamics of inhaled insulin

- adisonline.com [PDF] 
JS Patton, JG Bukar, MA Eldon - Clinical pharmacokinetics, 2004 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 781 1. The Pulmonary Route . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . 783 2. Current Status of Insulin Inhalation Systems . . . . . . . . . . . . . . . ...
Cited by 113 - Related articles - BL Direct - All 5 versions

Concept, strategies, and feasibility of noninvasive insulin delivery


WT Cefalu - Diabetes Care, 2004 - Am Diabetes Assoc
OBJECTIVE—To comprehensively review the progress to date on the development of alternative
routes for insulin delivery. ... RESEARCH DESIGN AND METHODS—Study data were collected
through a Medline review. ... RESULTS—Proof of principle has been established for ...
Cited by 71 - Related articles - BL Direct - All 10 versions

Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes …

- annals.org [PDF] 
L Ceglia, J Lau, AG Pittas - Annals of internal medicine, 2006 - Am Coll Physicians
Page 1. Meta-Analysis: Efficacy and Safety of Inhaled Insulin Therapy in Adults with
Diabetes Mellitus Lisa Ceglia, MD; Joseph Lau, MD; and Anastassios G. Pittas, MD,
MSc Background: Injection insulin therapy is not readily ...
Cited by 63 - Related articles - BL Direct - All 7 versions

The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled …


CCW Hsia, P Raskin - The American journal of medicine, 2005 - Elsevier
The alveolar-capillary network receives the entire cardiac output and constitutes the largest microvascular
organ in the body, making it highly susceptible to systemic microangiopathy. Owing to its large
reserves, symptoms and disability develop later in the lung than in smaller ...
Cited by 44 - Related articles - All 14 versions

Inhaled insulin: exubera


PS Odegard, KL Capoccia - The Annals of pharmacotherapy, 2005 - Harvey Whitney Books
Diabetes mellitus affects >18 million Americans.1 Type 1 diabetes is diagnosed most often in
children, adoles- cents, or young adults and is characterized by failure of the pancreatic islet
cells to produce insulin.2 Individuals with type 1 diabetes (~5–10% of those with ...
Cited by 42 - Related articles - All 4 versions

Novel pharmacologic agents for type 2 diabetes


GI Uwaifo, RE Ratner - Endocrinology and metabolism clinics of North America, 2005 - Elsevier
Since the discovery of insulin by Banting and Best in the early 20th century, the clinical management
of diabetes has undergone significant changes. The last decade has been associated with an
explosion in therapeutic options for management of type 2 diabetes that has significantly ...
Cited by 38 - Related articles - All 3 versions

Influence of acute upper respiratory tract infection on the absorption of inhaled …


A McElduff, LE Mather, PC Kam, P … - British journal of clinical …, 2005 - pubmedcentral.nih.gov
Normally healthy adult men (n = 11) and women (n = 9) received a single dose of inhaled human
insulin, equivalent to ~6 IU subcutaneous, using the AERx® insulin Diabetes Management System
(iDMS), during and following recovery from an URTI. The first dose was administered with ...
Cited by 35 - Related articles - All 6 versions

EXUBERA®: pharmaceutical development of a novel product for pulmonary …


S White, DB Bennett, S Cheu, PW Conley, DB … - Diabetes Technology …, 2005 - liebertonline.com
Page 1. DIABETES TECHNOLOGY & THERAPEUTICS Volume 7, Number 6, 2005 ©
Mary Ann Liebert, Inc. EXUBERA ® : Pharmaceutical Development of a Novel Product
for Pulmonary Delivery of Insulin STEVEN WHITE, BS ...
Cited by 35 - Related articles - BL Direct - All 3 versions

Carrier-based strategies for targeting protein and peptide drugs to the lungs

- aapsj.org [PDF] 
SA Cryan - The AAPS Journal, 2005 - Springer
With greater interest in delivery of protein and peptide-based drugs to the lungs for topical and
systemic activity, a range of new devices and formulations are being investigated. While a great
deal of recent research has focused on the development of novel devices, attention must ...
Cited by 36 - Related articles - All 4 versions

Current challenges in non-invasive insulin delivery systems: a comparative review


ES Khafagy, M Morishita, Y Onuki, K Takayama - Advanced Drug Delivery …, 2007 - Elsevier
The quest to eliminate the needle from insulin delivery and to replace it with non- or less-invasive
alternative routes has driven rigorous pharmaceutical research to replace the injectable forms
of insulin. Recently, various approaches have been studied involving many strategies ...
Cited by 33 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google